Delivery Order SPE2DB20D2001-SPE2DB25FPNTJ
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,258.08 on May 12, 2025, for the supply of Febuxostat 40 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion deadline of May 13, 2025. The contract will be performed at AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,747.98 to AmerisourceBergen Drug Corp for the supply of Febuxostat 40 mg tablets in quantities of 30, with an ultimate completion date of August 11, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,551.16 to AmerisourceBergen Drug Corp for the supply of Febuxostat 40 mg tablets (30-count units) on August 29, 2025, with completion scheduled for September 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of the companies' long-standing relationship supporting...
- The Defense Logistics Agency awarded a delivery order valued at $4,598.46 to AmerisourceBergen Drug Corp for the supply of Febuxostat 40 mg tablets (30-count packages) on July 14, 2025, with completion scheduled for July 15, 2025. This firm fixed-price delivery order represents a non-set-aside award made through open competition. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,768.65 to AmerisourceBergen Drug Corp for the supply of Febuxostat 40 mg tablets (30-count units) on September 4, 2025, with completion scheduled for September 5, 2025. This delivery order represents a firm fixed price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Febuxostat 40 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $1,394.19, with an ultimate completion date of August 15, 2025. The contract involves no set-aside designation and was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The U.S. Defense Department's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on August 5, 2025, for the supply of Febuxostat 40 mg tablets (30-count units) with a ceiling value of $2,139.55. This is a firm fixed-price, non-set-aside contract with performance expected at the company's Conshohocken, Pennsylvania facility and completion by August 6, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and SAM.gov-registered federal vendor, serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Febuxostat 80 mg tablets in quantities of 30, with a contract ceiling value of $1,191.79. This is a firm fixed price delivery order with an ultimate completion date of August 21, 2025, and represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Febuxostat 40 mg tablets (30-count packages) under a firm fixed-price contract valued at $4,061.04. This non-set-aside, competitively awarded delivery order is scheduled for completion by August 12, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $2,164.23 to AmerisourceBergen Drug Corp for the supply of Febuxostat 80 mg tablets (30-count units) under a firm fixed price contract. This non-set-aside award was executed on September 8, 2025, with an ultimate completion date of September 9, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB25FPNTJDelivery Order
The Defense Logistics Agency awarded a $4,615.48 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Febuxostat 40 mg tablets in quantities of 30, with completion targeted for September 19, 2025. The contract was awarded on a non-competitive basis and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete pharmaceutical procurement action supporting federal medical supply requirements. This award is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp maintains an extensive portfolio of competitively awarded federal contracts covering a wide spectrum of medications and medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 9/18/25 |